US FDA Set To Begin Training Patent Examiners This Spring

The US Food and Drug Administration will begin training examiners from the Patent and Trademark Office this spring on how to make the most of the information FDA makes available.

The training follows an earlier event where the patent office trained FDA staff on issues such as “where patent examiners search, what qualifies as prior art, [reasons for] rejecting patent applications, what the standards are for patentability, and also how FDA documents have been used to challenge patents in our post grant PTAB proceedings,” Linda Horner, Acting Vice Chief Judge for the U.S